Gabapentin Capsule
Product Images NDC 16714-663

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 16714-663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation Of Cockcroft And Gault (Gabapentin Fig1)

An illustration presenting the formula for calculating Creatinine Clearance (CLCr) based on age, weight, serum creatinine levels, and a correction factor for female patients. The formula is shown in a mathematical expression format.*

FDA Label Image

Fig-2 (Gabapentin Fig2)

Line graph depicting mean pain score over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis shows weeks from Baseline to Week 8; the y-axis shows mean pain score from 0 to 10. The graph highlights two periods: a 4-week dose titration and a 4-week fixed dose period. Gabapentin shows a decreasing trend in pain score, while placebo remains relatively stable.*

FDA Label Image

Fig-3 (Gabapentin Fig3)

A line graph depicting mean pain scores over seven weeks comparing placebo and two doses of Gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks including a 3-week dose titration period and a 4-week fixed dose period; the y-axis shows mean pain scores from 0 to 10. Gabapentin groups show a decline in pain scores, while placebo remains higher.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig4)

A bar chart illustrating the proportion of responders with at least 50% reduction in pain score at endpoint in controlled PHN studies for Gabapentin (GBP) versus placebo (PBO). The chart compares two studies with different GBP dosages (3600 mg for Study 1; 1800 mg and 2400 mg for Study 2), showing higher responder percentages for GBP groups compared to placebo, with statistical significance indicated.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

A scatter plot depicting the percentage difference versus daily dose in mg for Gabapentin. The graph shows data points from three studies labeled as STUDY a, STUDY b, and STUDY c, with daily doses on the x-axis ranging from 600 to 1800 mg and percentage difference on the y-axis ranging from 0% to 22%. Each study is represented by different symbols and letters associated with the data points.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Capsules Bottle))

Label for Gabapentin Capsules, USP 100 mg, oral capsules in a 100-count package from NorthStar Rx LLC. The label includes the NDC 16714-661-01, pharmacist dispensing instructions, storage conditions, manufacturing details by Aurobindo Pharma Limited, and contact information for Medication Guides. The design features blue and green text on a white background with a barcode on the right.*

FDA Label Image

Package Label-principal Display Panel (300 mg (100 Capsules Bottle))

Gabapentin Capsules, USP 300 mg oral capsules label from NorthStar Rx LLC. The label indicates a package size of 100 capsules and includes storage instructions, manufacturer details, a barcode, and a medication guide notice. The label also specifies the National Drug Code (NDC) 16714-662-01.*

FDA Label Image

Package Label-principal Display Panel (400 mg (100 Capsules Bottle))

Gabapentin Capsules, USP 400 mg oral capsules packaging label by NorthStar Rx LLC. The label indicates the product contains 100 capsules, with storage instructions and manufacturer details including Aurobindo Pharma Limited, India. It also includes dosage direction references, pharmacist instructions, and a barcode.*

FDA Label Image

Chemical Structure (Gabapentin Str)

Chemical structure of gabapentin, showing a cyclohexane ring bonded to amino and carboxymethyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.